New pharmacological avenues for the treatment of L-DOPA-induced dyskinesias in Parkinson's disease: targeting glutamate and adenosine receptors. [electronic resource]
Producer: 20120501Description: 153-68 p. digitalISSN:- 1744-7658
- Animals
- Antiparkinson Agents -- adverse effects
- Dyskinesias -- drug therapy
- Excitatory Amino Acid Antagonists -- therapeutic use
- Humans
- Levodopa -- adverse effects
- Parkinson Disease -- drug therapy
- Purinergic P1 Receptor Antagonists -- therapeutic use
- Receptors, Glutamate -- metabolism
- Receptors, Purinergic P1 -- metabolism
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.